Table 6 Time expedited in days between treatment steps in comparison between the 2019 and 2020 cohorts.

From: Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations

 

Treatment year

P

Total

2019

2020

Days between initial cMRI and resection, mean ± SD

16 ± 24

15 ± 24

18 ± 25

.441

Days between biopsy and resection, mean ± SD

28 ± 30

27 ± 16

29 ± 40

.866

Days between initial cMRI and biopsy*, mean ± SD

15 ± 22

11 ± 10

21 ± 32

.031

Days between resection and first RT, mean ± SD

34 ± 12

33 ± 11

35 ± 12

.426

Days between biopsy and first RT, mean ± SD

36 ± 22

37 ± 25

34 ± 19

.621

Days between last RT and first ST, mean ± SD

43 ± 93

35 ± 25

53 ± 134

.299

  1. cMRI—cranial magnetic resonance imaging; RT—radiotherapy; ST—systemic treatment; SD—standard deviation;
  2. *initial biopsy rate 2019: 31.3%; 2020: 23.8%.
  3. Significant values are in [bold].
Back to article page